107 Results for: created: (01/2018 to 01/2018)

People

  1. Adusumilli
    Adusumilli
  2. Eguchi
    Eguchi
  3. Jones
    Jones
  4. Travis
    Travis
  5. Lu
    Lu
  6. Rimner
    Rimner
  7. Zelefsky
    Zelefsky
  8. Zhang
    Zhang
  9. Downey
    Downey
  10. Kollmeier
    Kollmeier

Groups

  1. Department of Medicine (40)
  2. Surgery (39)
  3. Sloan Kettering Institute Postdocs (34)
  4. Solid Tumor Oncology Division (33)
  5. Epidemiology and Biostatistics (23)
  6. Radiation Oncology, Department of (22)
  7. Survivorship Research (21)
  8. Biostatistics Service (20)
  9. Department of Pathology and Laboratory Medicine (20)
  10. Thoracic Oncology (19)
  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (65)
  2. Journal Article (41)
  3. Book Section (1)
Groups
  1. Department of Medicine (40)
  2. Surgery (39)
  3. Sloan Kettering Institute Postdocs (34)
  4. Solid Tumor Oncology Division (33)
  5. Epidemiology and Biostatistics (23)
  6. Radiation Oncology, Department of (22)

More Groups

People
  1. Prasad Adusumilli (25)
  2. Takashi Eguchi (19)
  3. David Jones (17)
  4. William Travis (15)
  5. Shaohua Lu (11)
  6. Kay See Tan (9)

More People

Years
  1. 2018 (14)
  2. 2017 (79)
  3. 2015 (1)
  4. 2014 (1)
  5. 2012 (5)
  6. 2009 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (53)
  2. International Journal of Radiation Oncology, Biology, Physics (9)
  3. European Journal of Cancer (5)
  4. Radiotherapy and Oncology (5)
  5. Seminars in Radiation Oncology (4)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. Elsevier Inc. (107)

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab alone or with ipilimumab in recurrent small cell lung cancer (SCLC): 2-year survival and apdated analyses from the CheckMate 032 trial
    Meeting Abstract

    Hellmann, M.; Antonia, S.; Ponce, S.; Ott, P.; Calvo, E.; Taylor, M.; Ready, N.; Hann, C.; De Braud, F.; Eder, J. P.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Mechanistic insights into CAR T-cell efficacy in the treatment of heterogenous antigen expressing lung adenocarcinoma
    Meeting Abstract

    Morello, A.; Zeltsman, M.; Bograd, A.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A highly sensitive next-generation sequencing platform for detection of NSCLC EGFR T790M mutation in urine and plasma
    Meeting Abstract

    Wakelee, H.; Melnikova, V.; Karlovich, C.; Gadgeel, S.; Reckamp, K.; Goldman, J. W.; Camidge, D. R.; PeĢrol, M.; Ou, S. H.; Liu, S.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: Results from a phase II trial
    Meeting Abstract

    Byers, L. A.; Krug, L.; Waqar, S.; Dowlati, A.; Hann, C.; Chiappori, A.; Owonikoko, T.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) is associated with improved efficacy of atezolizumab in 1L and 2L+ NSCLC patients
    Meeting Abstract

    Kowanetz, M.; Zou, W.; Shames, D.; Cummings, C.; Rizvi, N.; Spira, A.; Frampton, G.; Leveque, V.; Flynn, S.; Mocci, S.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Quantifying survival in early-stage NSCLC: Implications of relative survival vs cause-specific survival
    Meeting Abstract

    Tan, K. S.; Eguchi, T.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Tumoral IL-7 receptor is a potential target for lung adenocarcinoma immunotherapy
    Meeting Abstract

    Lee, M. C.; Eguchi, T.; Tano, Z.; Kadota, K.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Single-agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC), in small-cell lung cancer (SCLC)
    Meeting Abstract

    Spigel, D.; Pietanza, M. C.; Bauer, T.; Ready, N.; Morgensztern, D.; Glisson, B. S.; Byers, L. A.; Johnson, M.; Burris, H.; Robert, F.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Histologic subtype of early-stage lung adenocarcinoma is a predictor of failure patterns after stereotactic body radiation therapy
    Meeting Abstract

    Leeman, J.; Rimner, A.; Montecalvo, J.; Hsu, M.; Zhang, Z.; Von Reibnitz, D.; Panchoo, K.; Yorke, E.; Adusumilli, P.; Travis, W.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save